ITPP (Myo-lnositol trispyrophosphate) is a natural phosphosugar derivative – well known for its ability to trigger the dissociation of molecular oxygen from haemoglobin. Experimental studies …
Read more
ITPP (Myo-lnositol trispyrophosphate) is a natural phosphosugar derivative – well known for its ability to trigger the dissociation of molecular oxygen from haemoglobin. Experimental studies …
Read more
The link below connects to a new paper which reviews a novel hypoxia marker – HypoxiTRAK™ – a homogeneous live-cell permeant reagent which provides a …
Read more
OncoTherics Poland has today successfully transformed from a Spółka z ograniczoną odpowiedzialnością (Sp. z o.o) to a Spółka akcyjna (S.A.) company as part of a …
Read more
OncoTherics CEO, Stefan Ogrodzinski, is due to showcase OncoTherics’ novel drug technology at the upcoming GPWInnovation day, sponsored by Trigon. The online conference aims to …
Read more
This review focuses on new pharmacological agents that exploit tumor hypoxia or interfere with hypoxia signaling and discusses strategies to maximize their therapeutic impact. Click …
Read more
OncoTherics’ CEO, Stefan Ogrodzinski, will be presenting a short session about the UK biotech/life sciences ecosystem. The talk will compare the UK ecosystem to the …
Read more
The high-profile event will also recognise the award of the Nobel prize to Professor Robert Huber for his seminal works on hypoxia. Prof. Zbigniew Madeja, …
Read more
Oncotherics Poland Sp. zo.o. is delighted to announce that it has secured a 11.7M PLN grant as part of the regional operational program of the …
Read more
Read more
The Nobel Prize in Physiology or Medicine 2019 has been awarded jointly to William G. Kaelin Jr, Sir Peter J. Ratcliffe and Gregg L. Semenza …
Read more
OncoTherics is currently raising first round funding. If you are interested in taking part, please provide your contact details so that we can include you on our contact list.
Are you working on a project where OncoTherics' technology might be of help or would you like to collaborate in our research? Please provide your contact details so that we can include you on our contact list.